Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.

MLA

Poluzzi, Elisabetta, et al. “Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database.” Drug Safety, vol. 36, no. 6, June 2013, pp. 467–79. EBSCOhost, https://doi.org/10.1007/s40264-013-0032-z.

APA

Poluzzi, E., Raschi, E., Koci, A., Moretti, U., Spina, E., Behr, E. R., Sturkenboom, M., & De Ponti, F. (2013). Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Safety, 36(6), 467–479. https://doi.org/10.1007/s40264-013-0032-z

Chicago

Poluzzi, Elisabetta, Emanuel Raschi, Ariola Koci, Ugo Moretti, Edoardo Spina, Elijah R Behr, Miriam Sturkenboom, and Fabrizio De Ponti. 2013. “Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database.” Drug Safety 36 (6): 467–79. doi:10.1007/s40264-013-0032-z.